Share
Market Research Report

ANTI-OBESITY DRUG MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Mechanism of ActionPeripherally Acting Anti-Obesity Drugs and Centrally Acting Anti-obesity Drugs
  • By Prescription/Non- prescriptionPrescription Drugs and OTC Drugs
  • Published In31 Mar 2026
  • Report CodeCMI2824
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Anti-Obesity Drug Market, By Drug Type
      • Global Anti-Obesity Drug Market, By Drug Class
      • Global Anti-Obesity Drug Market, By Route of Administration
      • Global Anti-Obesity Drug Market, By Type
      • Global Anti-Obesity Drug Market, By Gender
      • Global Anti-Obesity Drug Market, By Age Group
      • Global Anti-Obesity Drug Market, By Distribution Channel
      • Global Anti-Obesity Drug Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Anti-Obesity Drug Market, By Drug Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Prescription Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Over-the-Counter (OTC) Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Anti-Obesity Drug Market, By Drug Class, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • GLP-1 Receptor Agonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Semaglutide
          • Liraglutide
          • Tirzepatide
    • MC4R (Melanocortin-4 Receptor) Agonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Setmelanotide
    • Lipase Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Orlistat
    • Noradrenergic & Serotonergic Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Phentermine
          • Diethylpropion
          • Phendimetrazine
    • Combination Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Phentermine/Topiramate
          • Naltrexone/Bupropion
          • Others
    • Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Empagliflozin
          • Canagliflozin
    • Bile Acid Sequestrants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Colesevelam
    • Amylin Analogs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Pramlintide
    • Others (Late Phase Drugs, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Anti-Obesity Drug Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (Transdermal)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Anti-Obesity Drug Market, By Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Brand
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Anti-Obesity Drug Market, By Gender, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Male
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Female
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Anti-Obesity Drug Market, By Age Group, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Geriatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Anti-Obesity Drug Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  11. Global Anti-Obesity Drug Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  12. Competitive Landscape

    • Novo Nordisk
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Orexigen Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Zafgen
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Rhythm Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Currax Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  13. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  14. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Anti-Obesity Drug Market' - Global forecast to 2033